Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

Bioequivalence of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

The purpose of this study was to compare the relative vasoconstrictive effects of test and reference topical augmented betamethasone dipropionate augmented 0.05% cream in healthy, female subjects.

Inclusion Criteria:

• Non-tobacco-using female subjects, 18 to 50 years of age
• Demonstrated blanching response to Reference Drug (augmented betamethasone dipropionate) Cream 0.05%
• Weight within + or - 20% from normal for height and weight for body frame
• Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator
• Signed and dated informed consent form which meets all criteria of current FDA regulations

Exclusion Criteria:

• History of allergy to systemic or topical corticosteroids
• Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching
• Presence of medical condition requiring regular treatment with prescription drugs
• Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing
• Use of any dermatological drug therapy on the flexor surface of the forearms within 30 days of dosing
• Use of any tobacco products in the 30 days prior to study dosing
• Receipt of any drugs as part of a research study within 30 days prior to study dosing
• Pregnant or lactating